The NAGLU gene gives your cells instructions to make an enzyme that breaks down heparan sulfate, a natural sugar chain the body regularly recycles. If this enzyme does not work well, heparan sulfate builds up inside cells and can lead to Sanfilippo syndrome type B, a condition that often affects brain development, behavior, sleep, movement, and daily skills. This gene helps your body clear used materials from lysosomes, the cell’s recycling centers.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes give the directions for producing proteins, which are the functional parts of cells. Other genes mainly control the timing, location, and strength of certain processes. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to explore this topic more deeply, you can learn more in the LearnHub.
Overview
NAGLUGene function
What if the gene works
The NAGLU gene helps lysosomes, the cell’s recycling centers, break down heparan sulfate, a natural sugar chain. This supports normal cell cleanup, especially in the brain, liver, and other tissues.
Risk
What if the gene does not work
When the NAGLU gene does not work properly, sugars build up in cells and cause Sanfilippo syndrome type B. Delayed development, behavior changes, and gradual loss of skills are common. Milder and more severe variants can affect onset and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the NAGLU gene do not currently have an established NAGLU-specific treatment or drug selection approach in clinical guidelines. Care is mainly supportive, while enzyme replacement and gene therapy designed to restore NAGLU activity are under study.
Conditions associated with NAGLU
Gene function
What if the gene works
Your cells are always recycling worn out material. The NAGLU gene helps with one step in that cleanup process inside lysosomes (the cell's recycling compartments). It supports the normal breakdown of heparan sulfate, a sugar rich material found on cell surfaces and between cells. This keeps routine cell maintenance moving along.
The NAGLU gene helps cells take apart heparan sulfate, a long sugar chain found on cell surfaces and in the space around cells. This is a key part of how the NAGLU gene helps break down heparan sulfate during normal cell recycling.
Its protein works inside lysosomes (the cell's recycling compartments). There, it trims heparan sulfate into smaller pieces so the material can be processed step by step.
Heparan sulfate is regularly renewed as cells replace older surface and support molecules. NAGLU supports this turnover by helping old chains be broken down after they are brought into lysosomes.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
NAGLU gene variants often make the enzyme unstable, poorly folded, or less active, so cells cannot fully break down heparan sulfate, a complex sugar. Some variants leave partial activity, while more disruptive variants can nearly eliminate it; this spectrum often influences how much material builds up in lysosomes (the cell’s recycling centers). In people with Sanfilippo syndrome type B, less residual activity may be linked to earlier onset and a more pronounced course.
How variants are linked to conditions
Pathogenic variants in the NAGLU gene cause mucopolysaccharidosis type IIIB, also called Sanfilippo syndrome type B. This is a rare inherited condition that can affect development, behavior, sleep, and other body systems over time. In families looking for the link between NAGLU gene variants and Sanfilippo syndrome type B, the diagnosis is typically confirmed when disease causing variants are found in both copies of the gene.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some instances, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NAGLU, risk is mainly shaped by the gene changes themselves rather than lifestyle. Sanfilippo syndrome B usually happens when a child inherits disease-causing changes in both copies of NAGLU, so family history and having two carrier parents are the main factors that raise risk. There is not enough evidence to say that diet, exercise, or other daily habits lower this risk.
Inheritance of NAGLU variants
Variants in the NAGLU gene linked to MPS IIIB are inherited in an autosomal recessive pattern. This means a child usually inherits one NAGLU gene variant from each parent, and the parents are often healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how NAGLU variants are inherited depends on both parents passing on the changed gene copy.
What does my NAGLU result mean for my family?
For families with a disease-causing change in the NAGLU gene, relatives can sometimes carry the same change even if they feel well. Parents of a child with NAGLU-related Sanfilippo syndrome are usually carriers, and brothers, sisters, and other close relatives may also be carriers or, less often, be affected. This can matter for future pregnancies and for relatives who want to understand their own family planning risks.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for NAGLU variants usually uses a blood sample or saliva sample to read the NAGLU gene and look for changes in its DNA code. This can identify variants linked to mucopolysaccharidosis type IIIB, confirm a genetic diagnosis in the right clinical setting, or show whether someone carries a familial variant.
When should I consider getting a genetic test?
Genetic testing for the NAGLU gene can be worth considering if a child has signs of Sanfilippo syndrome type B, such as developmental slowing, speech loss, behavior changes, sleep problems, or a large liver. It can also help if this condition runs in the family or if parents want carrier testing before pregnancy.
A genetic result is only one part of your health story
A genetic finding can provide meaningful insight, but how much it reveals depends on the condition and on the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, or reacts to a drug, so the same treatment may work better for one person than for another. This is common and can influence both how well a medicine helps and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medications. It examines links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can help support more informed, individualized treatment decisions. If you want to explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the NAGLU gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
NAGLU entered medical genetics through research on Sanfilippo syndrome type B, a rare inherited condition recognized clinically before its genetic cause was known. In the 1980s and 1990s, researchers linked the condition to deficiency of the enzyme alpha-N-acetylglucosaminidase, and this led to identification of the NAGLU gene. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition became easier to classify at the molecular level. From these first observations, research expanded steadily. This made DNA based testing possible for affected families and helped separate Sanfilippo type B from other similar lysosomal storage conditions. Over time, the NAGLU gene also became part of efforts to develop targeted treatments and newborn screening approaches for rare genetic conditions.